CASP10: A Potential Drug Target for Apoptosis-Related Cysteine 鈥嬧?婸rotease

Target Name: CASP10

NCBI ID: G843

CASP10

CASP10: A Potential Drug Target for Apoptosis-Related Cysteine 鈥嬧?婸rotease

Introduction

Apoptosis, the process of programmed cell death, is a natural occurrence in the life cycle of all living organisms. It is a critical regulatory mechanism that helps maintain tissue homeostasis, removes damaged or dysfunctional cells, and defends against invading pathogens. The caspases, a family of proteins that play a central role in apoptosis, are essential for this process. The Cysteine 鈥嬧?媝rotease (CSP) family is a representative of apoptosis-related cysteine 鈥嬧?媝roteases, of which CASP10 is an important member. This article will introduce the role, properties and potential of CASP10 as a drug target or biomarker.

Properties of CASP10

CASP10 is a 44kDa protein that belongs to the CSP family. It is composed of a single polypeptide chain with a single central 尾-helix and two non-polar termini (N-terminus and C-terminus). Within cells, CASP10 is located in the cytoplasm, on the outer surface of the cell membrane.

The role of CASP10 in apoptosis

Apoptosis is an important programmed death process in cells. In the process of apoptosis, CASP10 plays a key role. When cells are stimulated by apoptotic signals, CASP10 is activated and enters the cytoplasm, where it participates in the degradation of a series of apoptosis-related proteins. For example, CASP10 can interact with AP-1 and degrade AP-1, thereby inhibiting apoptosis. In addition, CASP10 can also interact with LC3 during the autophagy process, degrade LC3, and further inhibit apoptosis.

The interaction of CASP10 with apoptosis-related proteins also suggests that CASP10 may interact with other molecules in the apoptosis signaling pathway. For example, CASP10 can interact with hydrolases in lysosomes to degrade intracellular proteins, such as Bcl-2, AP-1, and p53. These proteins all play important roles in apoptosis.

The role of CASP10 in tumors

Studies have found that CASP10 plays an important role in a variety of tumors. For example, in breast cancer, the expression level of CASP10 is significantly higher than in normal tissue. In addition, CASP10 is related to the invasion and metastasis of breast cancer and can be used as a potential target for breast cancer treatment.

Biomarker properties of CASP10

CASP10 can be used as a biomarker of apoptosis-related proteins to detect the progress of apoptosis. For example, the use of CASP10 antibodies can significantly increase the half-time of apoptosis in mice, thereby indirectly detecting the occurrence of apoptosis. In addition, by detecting the activity of CASP10, the process of apoptosis and the activity of apoptosis-related proteins can be evaluated.

Pharmacological significance of CASP10

As an apoptosis-related protein, CASP10 has important pharmacological significance. First, CASP10 can be used as a drug target to develop anti-apoptotic drugs. Due to the key role of CASP10 in the apoptosis process, the development of anti-apoptotic drugs can effectively treat many tumors, including breast cancer, lung cancer, colon cancer, etc.

Secondly, CASP10 can be used as a biomarker of apoptosis to evaluate the process of apoptosis and the activity of apoptosis-related proteins. By detecting the activity of CASP10, the process of apoptosis can be understood, thereby providing guidance for the treatment of apoptosis-related diseases.

in conclusion

CASP10 is an important apoptosis-related protein that plays a key role in the apoptosis process. Its activation can regulate the activity of apoptosis-related proteins and participate in the apoptosis process. CASP10 also interacts with other molecules in the apoptosis signaling pathway, suggesting its role in tumors. Using CASP10 as a biomarker of apoptosis-related proteins can effectively treat many tumors. Therefore, CASP10 is a potential drug target and can also be used as an apoptosis-related biomarker.

Protein Name: Caspase 10

Functions: Involved in the activation cascade of caspases responsible for apoptosis execution. Recruited to both Fas- and TNFR-1 receptors in a FADD dependent manner. May participate in the granzyme B apoptotic pathways. Cleaves and activates effector caspases CASP3, CASP4, CASP6, CASP7, CASP8 and CASP9. Hydrolyzes the small- molecule substrates, Tyr-Val-Ala-Asp-|-AMC and Asp-Glu-Val-Asp-|-AMC

The "CASP10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CASP10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets